Peter Lind

975 total citations
19 papers, 713 citations indexed

About

Peter Lind is a scholar working on Radiology, Nuclear Medicine and Imaging, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peter Lind has authored 19 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peter Lind's work include Thyroid Cancer Diagnosis and Treatment (9 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). Peter Lind is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (9 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). Peter Lind collaborates with scholars based in Austria, Sweden and Denmark. Peter Lind's co-authors include E. Kresnik, Peter Mikosch, Susanne Kohlfürst, H. J. Gallowitsch, Isabel Igerc, Iris Gomez, Johann Gasser, G. Kumnig, Ivo Rausch and Jacobo Cal-González and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Nuclear Medicine and Molecular Imaging and International Journal for Parasitology.

In The Last Decade

Peter Lind

19 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Lind Austria 12 324 253 151 133 128 19 713
Masakazu Abe Japan 13 91 0.3× 32 0.1× 107 0.7× 314 2.4× 48 0.4× 48 713
P Peltier France 14 363 1.1× 139 0.5× 105 0.7× 119 0.9× 111 0.9× 40 622
Esterita Accogli Italy 10 98 0.3× 64 0.3× 92 0.6× 599 4.5× 89 0.7× 16 1.1k
Tomáš Tichý Czechia 15 53 0.2× 15 0.1× 86 0.6× 84 0.6× 216 1.7× 57 682
Hans E. Wagner Switzerland 14 52 0.2× 138 0.5× 568 3.8× 42 0.3× 182 1.4× 38 957
Rei Ishikawa Japan 11 62 0.2× 12 0.0× 99 0.7× 77 0.6× 77 0.6× 25 424
Susen Burock Germany 18 131 0.4× 11 0.0× 108 0.7× 27 0.2× 148 1.2× 37 800
R Hale United Kingdom 13 42 0.1× 27 0.1× 79 0.5× 186 1.4× 70 0.5× 26 505
Sith Phongkitkarun Thailand 14 311 1.0× 26 0.1× 102 0.7× 120 0.9× 150 1.2× 37 649
Makoto Tanikawa Japan 20 46 0.1× 25 0.1× 227 1.5× 938 7.1× 95 0.7× 69 1.4k

Countries citing papers authored by Peter Lind

Since Specialization
Citations

This map shows the geographic impact of Peter Lind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Lind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Lind more than expected).

Fields of papers citing papers by Peter Lind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Lind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Lind. The network helps show where Peter Lind may publish in the future.

Co-authorship network of co-authors of Peter Lind

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Lind. A scholar is included among the top collaborators of Peter Lind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Lind. Peter Lind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Rausch, Ivo, et al.. (2015). Performance evaluation of the Biograph mCT Flow PET/CT system according to the NEMA NU2-2012 standard. EJNMMI Physics. 2(1). 26–26. 93 indexed citations
2.
Grossman, Ashley, Rudolf Arnold, Aurel Perren, et al.. (2010). ENETS Consensus Guidelines for the Management of Brain, Cardiac and Ovarian Metastases from Neuroendocrine Tumors. Neuroendocrinology. 91(4). 326–332. 61 indexed citations
3.
Sørensen, John Dalsgaard, et al.. (2009). Baggrundsundersøgelser ifm. udarbejdelse af Nationale Annekser til EN1990 og EN1991. 1 indexed citations
4.
Friis, Ν. F., et al.. (2008). Absence of strictly age-related resistance to Mycoplasma hyosynoviae infection in 6-week-old pigs. Veterinary Microbiology. 130(3-4). 385–390. 7 indexed citations
5.
Lind, Peter & Susanne Kohlfürst. (2006). Respective Roles of Thyroglobulin, Radioiodine Imaging, and Positron Emission Tomography in the Assessment of Thyroid Cancer. Seminars in Nuclear Medicine. 36(3). 194–205. 77 indexed citations
6.
Zöller, Michael, Isabel Igerc, E. Kresnik, et al.. (2006). Combined PET/CT in the follow-up of differentiated thyroid carcinoma: what is the impact of each modality?. European Journal of Nuclear Medicine and Molecular Imaging. 34(4). 487–495. 63 indexed citations
7.
Lind, Peter, Isabel Igerc, & Susanne Kohlfürst. (2005). Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer. Wiener Medizinische Wochenschrift. 155(19-20). 429–435. 1 indexed citations
8.
Gallowitsch, H. J., E. Kresnik, Johann Gasser, et al.. (2003). F-18 Fluorodeoxyglucose Positron-Emission Tomography in the Diagnosis of Tumor Recurrence and Metastases in the Follow-Up of Patients With Breast Carcinoma. Investigative Radiology. 38(5). 250–256. 126 indexed citations
9.
Lind, Peter, et al.. (2003). Computer Simulation of The Bullmoose Coal Preparation Plant. Coal Preparation. 23(3). 129–145. 5 indexed citations
10.
Gallowitsch, H. J., E. Kresnik, Johann Gasser, et al.. (2003). . Investigative Radiology. 38(5). 250–256. 4 indexed citations
12.
Mikosch, Peter, et al.. (1999). Lymphoscintigraphy and Gamma Probe–Guided Surgery in Papillary Thyroid Carcinoma. Clinical Nuclear Medicine. 24(10). 744–744. 32 indexed citations
13.
Gallowitsch, H. J., Peter Mikosch, E. Kresnik, et al.. (1998). Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.. PubMed. 39(5). 870–5. 32 indexed citations
14.
Mikosch, Peter, et al.. (1997). Gamma Probe-Guided Resection of a Lymph Node Metastasis With I-123 in Papillary Thyroid Carcinoma. Clinical Nuclear Medicine. 22(9). 591–592. 21 indexed citations
15.
Lind, Peter, et al.. (1997). Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma.. PubMed. 38(3). 348–52. 44 indexed citations
16.
Kresnik, E., et al.. (1997). Evaluation of thyroid nodules with technetium-99m tetrofosmin dual-phase scintigraphy. European Journal of Nuclear Medicine and Molecular Imaging. 24(7). 716–721. 1 indexed citations
17.
Hindsbo, O., Per Andersen, & Peter Lind. (1996). Worm kinetics and serum IgE in Hooded Lister rats infected with the acanthocephalan Moniliformis moniliformis and the nematode Nippostrongylus brasiliensis. International Journal for Parasitology. 26(11). 1287–1294. 2 indexed citations
18.
Cantrell, Amanda, Marita Högberg, S. Richard Jaskunas, et al.. (1996). Phenethylthiazolylthiourea (PETT) Compounds as a New Class of HIV-1 Reverse Transcriptase Inhibitors. 2. Synthesis and Further Structure−Activity Relationship Studies of PETT Analogs. Journal of Medicinal Chemistry. 39(21). 4261–4274. 104 indexed citations
19.
Langsteger, Werner, Peter Lind, P Költringer, Alfred Beham, & O Eber. (1990). Misinterpretation of iodine uptake in papillary thyroid carcinoma and primary lung adenocarcinoma. Journal of Cancer Research and Clinical Oncology. 116(1). 8–12. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026